Hematology News

The FDA granted priority review to crizanlizumab for prevention of vaso-occlusive crises among patients with sickle cell disease.

Several distinguished leaders in hematology will be honored with awards and special lectures at this year’s ASH Annual Meeting and Exposition, scheduled for Dec. 7-10 in Orlando, Florida.

Levon — an 18-year-old with sickle cell disease — enters the clinic room with his mom, who nervously allows him to proceed alone.

Placing an inferior vena cava filter in patients within 72 hours of major trauma did not reduce incidence of symptomatic pulmonary embolism or death at 90 days, according to results of a randomized prospective trial published in The New England Journal of Medicine.

Two hematologists at City of Hope have been appointed to new positions.

The FDA expanded the approval of avatrombopag to include treatment of adults with chronic immune thrombocytopenia who had insufficient response to previous treatment.

Red blood cell transfusions from female, previously pregnant or sex-discordant donors did not appear to increase risk for mortality among transfusion recipients, according to results of a retrospective study published in JAMA.

World Sickle Cell Day is held every June 19.

Voxelotor increased hemoglobin levels and reduced markers of hemolysis compared with placebo among patients with sickle cell disease, according to results of a randomized phase 3 study published in The New England Journal of Medicine and presented at European Hematology Association Congress in Amsterdam.

Among patients with thromboembolic disease treated with warfarin, increased consumption of foods containing vitamin K may improve anticoagulant stability, according to findings presented at the American Society for Nutrition Annual Nutrition Science Meeting.